Addex Therapeutics Q1 EPS $(1.53) Down From $(1.33) YoY, Sales $10.214K Down From $78.928K YoY

Benzinga Newsdesk www.benzinga.com Negative 96.9%

Neg 96.9% Neu 0% Pos 0%

Addex Therapeutics (NASDAQ:ADXN) reported quarterly losses of $(1.53) per share. This is a 15.04 percent decrease over losses of $(1.33) per share from the same period last year. The company reported $10.214 thousand in sales this quarter. This is a 87.06 percent decrease over sales of $78.928 thousand the same period last year.